Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Système intelligent ElderTree pour les personnes âgées

24 septembre 2026 mis à jour par: University of Wisconsin, Madison

Utilisation d'appareils intelligents pour mettre en œuvre un système de cybersanté fondé sur des données probantes pour les personnes âgées

Multiple chronic conditions (MCCs) are costly and pervasive among older adults. MCCs account for 90% of Medicare spending, and 65% of Medicare beneficiaries have 3 or more chronic conditions; 23% have 5 or more. MCCs are often addressed in primary care, where time pressures force a focus on medication and lab results rather than self-management skills.

The primary purpose of this study is to investigate whether voice-activated "smart" technology increases adoption and sustains use of an evidence-based electronic health intervention (Elder Tree, or ET) for older adults with multiple chronic conditions, and thereby improves its potential to widely enhance quality of life and health outcomes. ET is an existing intervention providing tools, motivation, and support on a computer platform to help older adults manage their health.

An Agency for Health Care Research and Quality (AHRQ)-funded randomized controlled trial (RCT) found that ET improved quality of life and other factors among high users of primary care with multiple chronic conditions such as diabetes and hypertension. However, many people did not use it extensively, which is a common problem with all web apps.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Réel)

268

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Wisconsin
      • Madison, Wisconsin, États-Unis, 53704
        • University of Wisconsin School of Medicine and Public Health

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

60 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Be ≥60 years old;
  • Have been treated in University of Wisconsin (UW) Health clinics, with no plans to leave during the study period (only relevant for UW Health patients, not patients recruited from the community);
  • Have a chronic pain diagnosis AND a medical diagnoses of three or more of the following common chronic conditions: Chronic obstructive pulmonary disease (COPD), asthma, diabetes, hyperlipidemia, hypertension, ischemic heart disease, atrial fibrillation, heart failure, stroke, BMI 30+, cancer, chronic kidney disease, depression, osteoporosis, arthritis, or dizziness/falls/loss of vestibular function;
  • Be willing to share healthcare use (e.g. 30-day readmissions) in electronic health records (only relevant for UW Health patients, not patients recruited from the community); and
  • Allow researchers to share information about a patient's health status with their primary care physician (PCP).

Exclusion Criteria:

  • Require an interpreter

  • Have a medical diagnosis of any of the following:

    • Alzheimer's
    • Schizophrenia/other psychotic disorders
    • Dementia
    • Autism spectrum disorder
    • Known terminal illness with less than 6 months to live
    • Acute medical problem requiring immediate hospitalization

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur placebo: Control group

Participants will receive treatment as usual (TAU).

Treatment as usual (TAU)

Expérimental: ElderTree on laptop (ET- LT)

Participants will receive ElderTree on a laptop.

ElderTree (ET) is an existing intervention providing tools, motivation, and support on a computer platform to help older adults manage their health.

ET is based on the extensively tested Comprehensive Health Enhancement Support System (CHESS). ET is a "walled garden" free of ads, with design features based on older users' feedback as well as best-practice principles such as uncluttered screens and large type. ET uses computers to deliver key elements of successful interventions: long duration, ongoing outreach, prompts, monitoring, cognitive reframing, action planning, problem solving, self-tailoring, and peer support. ET-LT arm will access ET on Laptop (ET- LT)

Expérimental: ElderTree on smart system (ET- SS)

Participants will receive ElderTree on a smart system.

ElderTree (ET) is an existing intervention providing tools, motivation, and support on a computer platform to help older adults manage their health.

ET is based on the extensively tested Comprehensive Health Enhancement Support System (CHESS). ET is a "walled garden" free of ads, with design features based on older users' feedback as well as best-practice principles such as uncluttered screens and large type. ET uses computers to deliver key elements of successful interventions: long duration, ongoing outreach, prompts, monitoring, cognitive reframing, action planning, problem solving, self-tailoring, and peer support.

ElderTree on smart system (ET- SS) will use voice-activated "smart" speakers connected to the Internet. Because they are used by talking and listening rather than typing and reading, many barriers associated with laptop use can be avoided.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.1 - Pain Interference Score
Délai: Baseline, 4 months, 8 months

Pain interference was measured using the 4-item subscale from the PROMIS 29. The items asked participants to answer regarding the past 7 days. Scoring of individual items varies and is calculated by the scale's developers; with higher values indicating more pain interference. The possible range is 41.1 to 76.3 (PROMIS scores reported here have weighted ranges).

Baseline, 4 months, 8 months
Change in PROMIS Short Form v2.1 - Psychosocial Quality of Life Score
Délai: Baseline, 4 months, 8 months

Psychosocial quality of life was measured using the 12-item subscale from the PROMIS 29. The items asked participants to answer regarding the past 7 days. Scoring of individual items varies and is calculated by the scale's developers; with higher values indicating better quality of life. The possible range is 21.2 to 67.6.

Baseline, 4 months, 8 months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
ElderTree Days of Use
Délai: baseline to 4 months, and 4 months to 8 months

Days of ElderTree use within a 4 month period before their survey date. The possible range for days of ElderTree use is 0 to 120.

baseline to 4 months, and 4 months to 8 months
Physical Quality of Life
Délai: Baseline, 4 months, 8 months

Physical quality of life was measured using the 12-item subscale from the PROMIS 29 (Patient-Reported Outcomes Measurement Information System) Global Health. The items asked participants to answer regarding the past 7 days. Scoring of individual items varies and is calculated by the scale's developers; with higher values indicating more physical quality of life. The possible range is 16.2-67.7.

Baseline, 4 months, 8 months
Pain Intensity
Délai: Baseline, 4 months, 8 months

Pain intensity was measured using a single item subscale from the PROMIS 29 (Patient-Reported Outcomes Measurement Information System) Global Health. The item asked participants to answer regarding the past 7 days. The raw score of the item was used (range: 0-10); with higher values indicating more pain intensity.

Baseline, 4 months, 8 months
Number of Participants Readmitted Within 30-days
Délai: Baseline, 4 months, 8 months

30-day readmissions were measured using a single item asking participants to answer regarding the past 4 months. The raw score, answering yes/no to having a 30-day readmission, was used. Those participants answering 'yes' to being readmitted in the last 30 days are reported for each time point.

Baseline, 4 months, 8 months
Health Distress
Délai: Baseline, 4 months, 8 months

Health distress was measured using the 4-item Lorig Health Distress Scale. The items asked participants to answer regarding the past month. The measure was scored by averaged the items; with higher values indicating more health distress. Possible range is 0 to 5.

Baseline, 4 months, 8 months
Well-being
Délai: Baseline, 4 months, 8 months

Well-being was measured using the 5-items World Health Organization (WHO) Well-Being Index. The items asked participants to answer regarding the past 7 days. The measure was scored by summing the items; with higher values indicating better well-being. Possible range is 0 to 25.

Baseline, 4 months, 8 months
Loneliness
Délai: Baseline, 4 months, 8 months

Loneliness was measured using the 5-item NIH Toolbox Social Relationship Scale Loneliness. The items asked participants to answer regarding the past month. Scoring of individual items varies and is calculated by the scale's developers; with higher values indicating more Loneliness. Possible range is 20 to 80.

Baseline, 4 months, 8 months
Irritability
Délai: Baseline, 4 months, 8 months

Irritability was measured using the 5-item Brief Irritability Test. The items asked participants to answer regarding the past 7 days. The measure was scored by summing the items; with higher values indicating more irritability. Possible range is 5 to 30.

Baseline, 4 months, 8 months
Communication With Physicians
Délai: Baseline, 4 months, 8 months

Communication with physicians was measured using the 3-item Lorig Communication with Physicians. The items asked participants to answer regarding the past 4 months. The measure was scored by averaging the items; with higher values indicating better communication with the healthcare provider. Possible range is 0 to 5.

Baseline, 4 months, 8 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: David H. Gustafson, PhD, UW-Madison

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

29 juillet 2021

Achèvement primaire (Réel)

26 septembre 2023

Achèvement de l'étude (Réel)

26 septembre 2023

Dates d'inscription aux études

Première soumission

11 mars 2021

Première soumission répondant aux critères de contrôle qualité

11 mars 2021

Première publication (Réel)

15 mars 2021

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

28 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

24 septembre 2026

Dernière vérification

1 octobre 2024

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 2020-0868
  • ENGR/INDUSTRIAL ENGR (Autre identifiant: UW Madison)
  • A195000 (Autre identifiant: UW Madison)
  • Protocol Version 10/20/2021 (Autre identifiant: UW Madison)
  • 1R18HS026853-01A1 (Subvention/contrat AHRQ des États-Unis)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner